Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.

Authors:
Li R; Qiu J; Li Z; Li H; Tang Z and 3 more

Journal:
World J Surg Oncol

Publication Year: 2024

DOI:
10.1186/s12957-024-03303-x

PMCID:
PMC10809442

PMID:
38273367

Journal Information

Full Title: World J Surg Oncol

Abbreviation: World J Surg Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis retrospective study was performed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Qilu Hospital of Shandong University. A waiver of informed consent was obtained due to the retrospective nature of the study. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was funded by the National Key R&D Program of China (2021YFC2500904, 2021YFC2500905 and 2021YFC2500900), Shandong Provincial Natural Science Foundation (ZR2023MH130, ZR2017BH035), China Postdoctoral Science Foundation (2020M672073), and National Natural Science Foundation of China (81802397)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025